Literature DB >> 19348896

Chapter 17 Type II NADH: quinone oxidoreductases of Plasmodium falciparum and Mycobacterium tuberculosis kinetic and high-throughput assays.

Nicholas Fisher1, Ashley J Warman, Stephen A Ward, Giancarlo A Biagini.   

Abstract

Type II NADH: quinone oxidoreductases (ndh) are flavoenzymes found in a broad range of organisms including plants, fungi, protozoa, and bacteria. The ndh enzymes catalyze the oxidation of NADH with concomitant reduction of quinone (Q). These membrane-bound respiratory enzymes differ from the canonical NADH: dehydrogenase (complex I), because they are not involved in the vectorial transfer of protons across membranes. In Plasmodium falciparum and Mycobacterium tuberculosis, causative agents of malaria and tuberculosis, respectively, ndhs have aroused interest because of the essential role played in maintaining a reduced Q-pool during infection. In this chapter, we present methods for the measurement of steady-state parameters for ndhs from both pathogens, highlighting best practices and caveats. In addition, owing to the interest in ndhs as potential chemotherapeutic targets, we describe a miniaturized endpoint assay that is validated for high-throughput screening (HTS) of chemical libraries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348896     DOI: 10.1016/S0076-6879(08)04417-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  15 in total

1.  Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone.

Authors:  Renata Tonhosolo; Heloisa B Gabriel; Miriam Y Matsumura; Fernanda J Cabral; Márcio M Yamamoto; Fábio L D'Alexandri; Rodrigo A C Sussmann; Rodrigo Belmonte; Valnice J Peres; Dean C Crick; Gerhard Wunderlich; Emília A Kimura; Alejandro M Katzin
Journal:  FEBS Lett       Date:  2010-10-29       Impact factor: 4.124

2.  Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.

Authors:  Edinson Lucumi; Claire Darling; Hyunil Jo; Andrew D Napper; Rajesh Chandramohanadas; Nicholas Fisher; Alison E Shone; Huiyan Jing; Stephen A Ward; Giancarlo A Biagini; William F DeGrado; Scott L Diamond; Doron C Greenbaum
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

3.  Physiological uncoupling of mitochondrial oxidative phosphorylation. Studies in different yeast species.

Authors:  Sergio Guerrero-Castillo; Daniela Araiza-Olivera; Alfredo Cabrera-Orefice; Juan Espinasa-Jaramillo; Manuel Gutiérrez-Aguilar; Luís A Luévano-Martínez; Armando Zepeda-Bastida; Salvador Uribe-Carvajal
Journal:  J Bioenerg Biomembr       Date:  2011-06       Impact factor: 2.945

4.  HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex.

Authors:  Cindy Vallières; Nicholas Fisher; Thomas Antoine; Mohammed Al-Helal; Paul Stocks; Neil G Berry; Alexandre S Lawrenson; Stephen A Ward; Paul M O'Neill; Giancarlo A Biagini; Brigitte Meunier
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

5.  Arrested oocyst maturation in Plasmodium parasites lacking type II NADH:ubiquinone dehydrogenase.

Authors:  Katja E Boysen; Kai Matuschewski
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

6.  Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.

Authors:  Giancarlo A Biagini; Nicholas Fisher; Alison E Shone; Murad A Mubaraki; Abhishek Srivastava; Alisdair Hill; Thomas Antoine; Ashley J Warman; Jill Davies; Chandrakala Pidathala; Richard K Amewu; Suet C Leung; Raman Sharma; Peter Gibbons; David W Hong; Bénédicte Pacorel; Alexandre S Lawrenson; Sitthivut Charoensutthivarakul; Lee Taylor; Olivier Berger; Alison Mbekeani; Paul A Stocks; Gemma L Nixon; James Chadwick; Janet Hemingway; Michael J Delves; Robert E Sinden; Anne-Marie Zeeman; Clemens H M Kocken; Neil G Berry; Paul M O'Neill; Stephen A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

7.  Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).

Authors:  Suet C Leung; Peter Gibbons; Richard Amewu; Gemma L Nixon; Chandrakala Pidathala; W David Hong; Bénédicte Pacorel; Neil G Berry; Raman Sharma; Paul A Stocks; Abhishek Srivastava; Alison E Shone; Sitthivut Charoensutthivarakul; Lee Taylor; Olivier Berger; Alison Mbekeani; Alasdair Hill; Nicholas E Fisher; Ashley J Warman; Giancarlo A Biagini; Stephen A Ward; Paul M O'Neill
Journal:  J Med Chem       Date:  2012-02-24       Impact factor: 7.446

8.  A yeast expression system for functional and pharmacological studies of the malaria parasite Ca²⁺/H⁺ antiporter.

Authors:  J Enrique Salcedo-Sora; Steve A Ward; Giancarlo A Biagini
Journal:  Malar J       Date:  2012-08-01       Impact factor: 2.979

9.  Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).

Authors:  Chandrakala Pidathala; Richard Amewu; Bénédicte Pacorel; Gemma L Nixon; Peter Gibbons; W David Hong; Suet C Leung; Neil G Berry; Raman Sharma; Paul A Stocks; Abhishek Srivastava; Alison E Shone; Sitthivut Charoensutthivarakul; Lee Taylor; Olivier Berger; Alison Mbekeani; Alasdair Hill; Nicholas E Fisher; Ashley J Warman; Giancarlo A Biagini; Stephen A Ward; Paul M O'Neill
Journal:  J Med Chem       Date:  2012-02-24       Impact factor: 7.446

10.  Antitubercular pharmacodynamics of phenothiazines.

Authors:  Ashley J Warman; Teresa S Rito; Nicholas E Fisher; Darren M Moss; Neil G Berry; Paul M O'Neill; Stephen A Ward; Giancarlo A Biagini
Journal:  J Antimicrob Chemother       Date:  2012-12-09       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.